General

Showing 1729–1744 of 2282 results

Article: P4.06 Cost minimization analysis of a home administration program in Belgium
€3.03 Add to cart
Article: P4.06 Identification of Integrin-av as an important marker of primitive hematopoietic stem cells in mouse and human
€3.03 Add to cart
Article: P4.07 Clinical and Immunological Predictive Factors of Late Infection Burden After Alternative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
€3.03 Add to cart
Article: P4.07 Diagnosis of congenital von Willebrand disease during a pre-operative screening in a multiple myeloma patient
€3.03 Add to cart
Article: P4.07 Identification of a TPM3-PDGFRB fusion transcript and its chromosomal breakpoints by RNA-Seq in a case of Chronic Eosinophilic Leukemia
€3.03 Add to cart
Article: P4.08 Disease risk index fails to predict survival after allogeneic peripheral blood stem cell transplantation (PBSCT) – Are multiple myeloma and myeloproliferative neoplasms misclassified?
€3.03 Add to cart
Article: P4.08 Two cases of atypical CALR mutations in MPN patients
€3.03 Add to cart
Article: P4.08 Two cases of immune-mediated early-onset neonatal thrombocytopenia: a case presentation
€3.03 Add to cart
Article: P4.09 A novel HLA-C null variant allele (C*05:XXN) generated by single nucleotide deletion and premature stop codon in exon 3
€3.03 Add to cart
Article: P4.09 Evaluation of Schistocyte Analysis by a Novel Automated Digital Cell Morphology Application
€3.03 Add to cart
Article: P4.09 MPL S204P is a Recurrent Mutation in Essential Thrombocythemia
€3.03 Add to cart
Article: P4.10 De novo thrombotic microangiopathy after non-renal solid organ transplantation
€3.03 Add to cart
Article: P4.10 Imatinib improves survival of chronic Graft-versus-Host disease by inhibiting TGF-beta and PDGF-r pathways in mice
€3.03 Add to cart
Article: P4.10 The Ponatinib Named Patient Programme (NPP): Real-life Data from Belgian Patients
€3.03 Add to cart
Article: P4.11 Genetic correction of induced pluripotent stem cells from a Wiskott-Aldrich Syndrome patient normalizes the immune defects
€3.03 Add to cart
Article: P4.11 Influence of platelet clumps on platelet function analyzer (PFA)-200® testing
€3.03 Add to cart

Article: P4.06 Cost minimization analysis of a home administration program in Belgium

Article: P4.06 Identification of Integrin-av as an important marker of primitive hematopoietic stem cells in mouse and human

Article: P4.07 Clinical and Immunological Predictive Factors of Late Infection Burden After Alternative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Article: P4.07 Diagnosis of congenital von Willebrand disease during a pre-operative screening in a multiple myeloma patient

Article: P4.07 Identification of a TPM3-PDGFRB fusion transcript and its chromosomal breakpoints by RNA-Seq in a case of Chronic Eosinophilic Leukemia

Article: P4.08 Disease risk index fails to predict survival after allogeneic peripheral blood stem cell transplantation (PBSCT) – Are multiple myeloma and myeloproliferative neoplasms misclassified?

Article: P4.08 Two cases of atypical CALR mutations in MPN patients

Article: P4.08 Two cases of immune-mediated early-onset neonatal thrombocytopenia: a case presentation

Article: P4.09 A novel HLA-C null variant allele (C*05:XXN) generated by single nucleotide deletion and premature stop codon in exon 3

Article: P4.09 Evaluation of Schistocyte Analysis by a Novel Automated Digital Cell Morphology Application

Article: P4.09 MPL S204P is a Recurrent Mutation in Essential Thrombocythemia

Article: P4.10 De novo thrombotic microangiopathy after non-renal solid organ transplantation

Article: P4.10 Imatinib improves survival of chronic Graft-versus-Host disease by inhibiting TGF-beta and PDGF-r pathways in mice

Article: P4.10 The Ponatinib Named Patient Programme (NPP): Real-life Data from Belgian Patients

Article: P4.11 Genetic correction of induced pluripotent stem cells from a Wiskott-Aldrich Syndrome patient normalizes the immune defects

Article: P4.11 Influence of platelet clumps on platelet function analyzer (PFA)-200® testing